Ginkgo Smart

Ginkgo Smart

Irwin Naturals4.6 (2,381 ratings)
Format:Softgel Quantity: 60 Liquid(s) · 30 servings
Goals
$14.99 $0.49 per serving

Product analysis

43 out of 100

Ginkgo Smart combines ginkgo with other ingredients for attention and memory support, though ginkgo findings are mixed. Unclear ginkgo preparation details limit how confidently those benefits apply.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality20

Most ingredient forms are unspecified, including the omega-3 form. Several named forms are present, but they do not establish the quality of the complete combination.

Ingredient Transparency65

Most amounts are listed, but few ingredient forms are identified. Some composition details are clear, while one part of the formula remains uncertain.

Value For Money28

The cost is unfavorable when judged by the amount of deanol. Value for the other ingredients remains uncertain, including omega-3 without a usable EPA and DHA comparison.

Customer Satisfaction83

Customer ratings are generally very positive. A substantial number of ratings gives a broad view of customer satisfaction.

Product Focus41

Ginkgo provides the main link to attention and memory, with mixed evidence. Small supporting amounts offer limited grounds for expecting a noticeable boost in everyday productivity.

Format
Softgel
Container
60 Liquid(s)
Per serving
$0.49
Customer rating
4.6 · 2,381 ratings
Report analysis

Goals

Brain Health
Impact
Moderate effect
C Ingredient FitD- PathwaysC- EvidenceA+ Formulation Logic

Ginkgo at 520 mg provides the main reviewed connection to brain energy processes. The 25 mg acetyl L-carnitine adds little at this amount, and the fish-oil total does not provide a declared DHA amount for evaluating neuronal membrane support.

How this product is rated for Brain Health

Ingredient fit62

The formula serves broader purposes, with a smaller share directly relevant to brain health. The counted ingredient amounts reach the saved comparison benchmarks.
Goal fit
The formula serves broader purposes, with a smaller share directly relevant to brain health.
Dose adequacy
The counted ingredient amounts reach the saved comparison benchmarks.

Pathways43

The clearest connection is to brain energy processes, with substantial coverage in the saved findings. One reviewed mechanism has sufficient support; the overall range remains narrow.
Depth
The clearest connection is to brain energy processes, with substantial coverage in the saved findings.
Breadth
One reviewed mechanism has sufficient support; the overall range remains narrow.

Evidence58

Ginkgo provides the strongest evidence among ingredients counted at a meaningful amount. The practical benefit remains dependent on context. The counted ingredients at meaningful amounts match preparations accepted in the saved assessment.
Evidence strength
Ginkgo provides the strongest evidence among ingredients counted at a meaningful amount. The practical benefit remains dependent on context.
Studied preparation
The counted ingredients at meaningful amounts match preparations accepted in the saved assessment.

Formulation logic100

The relevant ingredients can contribute independently or have their required partner. No ingredient conflicts were identified in the saved assessment.
Partner coverage
The relevant ingredients can contribute independently or have their required partner.
Conflicts
No ingredient conflicts were identified in the saved assessment.
Effective doses
1 of 1 relevant ingredients reach the saved meaningful-amount threshold.
Study evidence
Ginkgo Supportive 90 studies
Cognitive Support
Impact
Moderate effect
C+ Ingredient FitD- PathwaysF EvidenceA+ Formulation Logic
Choline · 30 mg

Ginkgo is the main cognitive-related ingredient, with preliminary attention-speed relevance that depends on the extract. The 520 mg declaration does not confirm the preparation used in the reviewed work.

The small choline, DMAE and acetyl L-carnitine amounts offer limited grounds for an added effect. Fish oil at 600 mg does not establish a DHA amount, and huperzine-source material adds no reliable general cognitive benefit.

How this product is rated for Cognitive Support

Ingredient fit68

Ginkgo supplies the saved contribution within a broader blend. The recorded amounts provide full exposure compared with the review's reference amounts.
Goal fit
Ginkgo supplies the saved contribution within a broader blend.
Dose adequacy
Recorded exposure is full compared with the reviewed reference amounts; undisclosed amounts cannot support an exposure estimate.

Pathways40

The strongest recorded area is cerebral blood flow, with moderate coverage. Only cerebral blood flow reaches the saved coverage threshold.
Depth
The strongest recorded area is cerebral blood flow, with moderate coverage.
Breadth
Only cerebral blood flow reaches the saved coverage threshold.

Evidence25

Ginkgo supplies the strongest saved evidence contribution. The saved review does not match Ginkgo to the studied preparations.
Evidence strength
Ginkgo supplies the strongest evidence contribution among ingredients meeting the saved exposure threshold; this does not predict an individual's benefit.
Studied preparation
The saved review does not match Ginkgo to the studied preparations.

Formulation logic100

All 1 contributing ingredient reaches the saved minimum exposure threshold. No conflict was matched in the saved checks.
Partner coverage
The saved review records no missing required partner for the contributing ingredients.
Conflicts
No conflict was matched in the saved checks.
Effective doses
All 1 contributing ingredient reaches the saved minimum exposure threshold.
Study evidence
Choline Supportive 76 studies
Deanol No effect 2 studies
Ginkgo Supportive 87 studies
Productivity Boost
Impact
Moderate effect
C Ingredient FitF PathwaysD+ EvidenceA+ Formulation Logic
Omega-3 · 180 mg

Ginkgo is the main connection to memory and attention, although cognitive findings are mixed. Its 520 mg amount earns no extra support over the saved reference range.

The declared 180 mg omega-3 amount is small against the saved comparison reference, and evidence does not support a dependable increase in everyday work output.

How this product is rated for Productivity Boost

Ingredient fit60

Ginkgo is the main relevant ingredient within a broad mixture. The ginkgo amount fully meets the saved reference; omega-3 falls below the saved minimum.
Goal fit
Ginkgo is the main relevant ingredient within a broad mixture.
Dose adequacy
The ginkgo amount fully meets the saved reference; omega-3 falls below the saved minimum.

Pathways13

Memory-related processes are the main connection.
Depth
Memory-related processes are the main connection.
Breadth
No area reaches the saved threshold for broad support across several mechanisms.

Evidence53

Ginkgo supplies the main evidence, which remains limited for routine productivity. The saved assessment accepts the ginkgo preparation.
Evidence strength
Ginkgo supplies the main evidence, which remains limited for routine productivity.
Studied preparation
The saved assessment accepts the ginkgo preparation.

Formulation logic100

Ginkgo meets the saved minimum amount. No ingredient conflicts were identified in the saved checks.
Partner coverage
The assessed ingredients can contribute on their own or have their required partner.
Conflicts
No ingredient conflicts were identified in the saved checks.
Effective doses
Ginkgo meets the saved minimum amount.
Study evidence
Ginkgo Supportive 20 studies
Omega-3 Supportive 46 studies
Mental Focus
Impact
Moderate effect
C Ingredient FitD- PathwaysC EvidenceA+ Formulation Logic
Choline · 30 mg

Ginkgo is the main focus-related botanical, with mixed evidence for attention. The 30 mg choline and 25 mg acetyl L-carnitine amounts make smaller supporting contributions through neurotransmitter and cellular-energy roles, without clear evidence of an immediate concentration boost.

How this product is rated for Mental Focus

Ingredient fit60

Focus-related ingredients sit within a broader formula containing ingredients for other purposes. The ingredients counted in the saved assessment meet its reference amounts.
Goal fit
Focus-related ingredients sit within a broader formula containing ingredients for other purposes.
Dose adequacy
The ingredients counted in the saved assessment meet its reference amounts.

Pathways44

The strongest saved connection is cerebral energy supply, with partial coverage. One assessed mechanism reaches the saved coverage threshold, so the focus support is relatively narrow.
Depth
The strongest saved connection is cerebral energy supply, with partial coverage.
Breadth
One assessed mechanism reaches the saved coverage threshold, so the focus support is relatively narrow.

Evidence62

Ginkgo provides the strongest evidence contribution among the ingredients meeting the saved amount criteria; that finding does not guarantee a focus benefit. The ingredients counted at relevant amounts match the preparations accepted by the saved assessment.
Evidence strength
Ginkgo provides the strongest evidence contribution among the ingredients meeting the saved amount criteria; that finding does not guarantee a focus benefit.
Studied preparation
The ingredients counted at relevant amounts match the preparations accepted by the saved assessment.

Formulation logic100

The counted ingredients can contribute independently or have their relevant partner present. No configured ingredient conflict was identified in the saved findings. All ingredients counted in this finding reach its minimum amount threshold.
Partner coverage
The counted ingredients can contribute independently or have their relevant partner present.
Conflicts
No configured ingredient conflict was identified in the saved findings.
Effective doses
All ingredients counted in this finding reach its minimum amount threshold.
Study evidence
Choline Supportive 22 studies
Ginkgo Supportive 28 studies
Impact
Limited evidence
F Ingredient FitF PathwaysF EvidenceB Formulation Logic
Study evidence
Ginkgo Supportive 11 studies

Ingredients

IngredientAmount per servingScore
Calories
15 Calorie(s)
Total Fat
1 Gram(s)
Cholesterol
5 mg
Protein
1 Gram(s)
Choline (Choline Bitartrate)
30 mg 44
Fish Oil
600 mg 6
Omega-3 Fatty Acids
180 mg 16
Ginkgo, Powder (Ginkgo biloba, Powder)
400 mg 58
Ginkgo Leaf Extract
120 mg 58
Flavone Glycosides
28.8 mg
Terpene Lactones
7.2 mg
Dimethylaminoethanol Bitartrate
40 mg 73
Trimethylglycine Hydrochloride
40 mg
Acetyl-L-Carnitine (Acetyl-L-Carnitine Hydrochloride)
25 mg
Alpha-Lipoic Acid
15 mg
Velvet Bean seed extract
10 mg
Toothed Clubmoss Leaf Extract
1 mg
BioPerine Complex
6 mg
BioPerine (Black Pepper Fruit Extract)
0 NP
Ginger Rhizome Extract (Gingerols)
0 NP
Adults 18–50 Women
Report overview
Deanol · 40 mg OverallScore73
A+ Active Ingredient Quality & BioavailabilityB Dose, Safety & Label TransparencyF Value
Each serving supplies 40 mg of active DMAE from DMAE bitartrate, a relatively modest amount in the evaluation. The whole-product cost is about $1.25 per 100 mg of active DMAE.
How this ingredient is rated

Active Ingredient Quality & Bioavailability100

DMAE bitartrate is identified, and the active DMAE amount is stated as 40 mg per serving.
Deanol Form Specificity
The saved facts identify DMAE bitartrate as the form.
Active Deanol Yield Transparency
The declared active DMAE amount is 40 mg per serving.

Dose, Safety & Label Transparency78

Each serving supplies 40 mg of active DMAE, a relatively modest amount in the evaluation. The saved facts record a DMAE-related warning without its wording.
Dosage Appropriateness
Each serving provides 40 mg of active DMAE, a relatively modest amount in the evaluation.
Specific Safety Warnings
The saved facts record a DMAE-related warning, but do not provide its wording.

Value10

The whole-product cost works out to about $1.25 per 100 mg of active DMAE.
Price Per 100mg Active Deanol
Based on the whole-product price, 100 mg of active DMAE corresponds to about $1.25.
D+ Active Ingredient Quality & BioavailabilityD Dose, Safety & Label TransparencyF Value
Each serving provides 30 mg of choline from choline bitartrate. The saved ingredient data flags an additive, and a whole-product serving costs about $0.50.
How this ingredient is rated

Active Ingredient Quality & Bioavailability53

Choline Bitartrate is a standard source of choline. The saved ingredient data flags an additive.
Choline Form Efficacy & Bioavailability
Choline Bitartrate is a standard form used to supply choline.
Formula Purity & Excipient Quality
The saved ingredient data flags an additive, but does not identify it.

Dose, Safety & Label Transparency47

The label states 30 mg choline per serving and identifies its source, making the amount clear.
Choline Dose by Declared Basis
Each serving provides 30 mg of choline, a small amount.
Elemental Yield Transparency
The label states the choline amount and identifies choline bitartrate as its source.

Value20

The whole-product serving costs about $0.50, which is high relative to its choline amount.
Price per 100 mg of Declared Choline Basis
The whole-product price works out to about $1.67 per 100 mg of choline.
F Composition And Label DisclosureA+ Composition And Label Disclosure
Each serving lists 400 mg of ginkgo powder and 120 mg of ginkgo leaf extract. The extract is recorded as containing 24% flavones and 6% terpenes.
How this ingredient is rated

Composition and Label Disclosure16

The leaf extract has 24% flavones and 6% terpenes in the saved details; marker percentages for the powder are unavailable.
Marker and Preparation Disclosure
The leaf extract has 24% flavones and 6% terpenes in the saved details; marker percentages for the powder are unavailable.
Declared Ginkgolic Acid Limit
No qualifying ginkgolic acid limit is recorded for either preparation; the actual content is unknown.

Composition and Label Disclosure100

The serving lists the powder and leaf extract separately, at 400 mg and 120 mg respectively.
Individual Preparation Amount Disclosure
The serving lists the powder and leaf extract separately, at 400 mg and 120 mg respectively.

Commercial Price and Usability

The whole-product serving costs about $0.50; that price covers the entire product, not ginkgo alone.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.
    Malaguarnera M; Gargante MP; Cristaldi E; Vacante M; Risino C; Cammalleri L; Pennisi G; Rampello L · Digestive diseases and sciences · 2008
    Randomized trial125 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  2. Long-term acetyl-L-carnitine treatment in Alzheimer's disease.
    Spagnoli A; Lucca U; Menasce G; Bandera L; Cizza G; Forloni G; Tettamanti M; Frattura L; Tiraboschi P; Comelli M · Neurology · 1991
    Randomized trial130 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  3. Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
    Herrmann WM; Dietrich B; Hiersemenzel R · International journal of clinical pharmacology research · 1990
    Randomized trialBrain Health forAcetyl L-Carnitine
  4. Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.
    Malaguarnera M; Vacante M; Motta M; Giordano M; Malaguarnera G; Bella R; Nunnari G; Rampello L; Pennisi G · Metabolic brain disease · 2012
    Randomized trial61 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  5. Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
    Passeri M; Cucinotta D; Bonati PA; Iannuccelli M; Parnetti L; Senin U · International journal of clinical pharmacology research · 1990
    Randomized trial60 participantsBrain Health Mental Focus forAcetyl L-Carnitine
  6. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health forGinkgo
  7. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledBrain Health Cognitive Support forGinkgo
  8. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Productivity Boost forGinkgo
  9. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  10. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  11. A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys.
    Torrioli MG; Vernacotola S; Peruzzi L; Tabolacci E; Mila M; Militerni R; Musumeci S; Ramos FJ; Frontera M; Sorge G; Marzullo E; Romeo G; Vallee L; Veneselli E; Cocchi E; Garbarino E; Moscato U; Chiurazzi P; D'Iddio S; Calvani M; Neri G · American journal of medical genetics. Part A · 2008
    Randomized trial63 participantsCognitive Support forAcetyl L-Carnitine
  12. Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
    Malaguarnera M; Gargante MP; Cristaldi E; Colonna V; Messano M; Koverech A; Neri S; Vacante M; Cammalleri L; Motta M · Archives of gerontology and geriatrics · 2008
    Randomized trial96 participantsCognitive Support forAcetyl L-Carnitine
  13. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
    De Jesus Moreno Moreno M · Clinical therapeutics · 2003
    Randomized trial261 participantsCognitive Support forCholine
  14. Association of dietary choline intake with incidence of dementia, Alzheimer disease, and mild cognitive impairment: a large population-based prospective cohort study.
    Niu YY; Yan HY; Zhong JF; Diao ZQ; Li J; Li CP; Chen LH; Huang WQ; Xu M; Xu ZT; Liang XF; Li ZH; Liu D · The American journal of clinical nutrition · 2025
    Cohort study125,594 participantsCognitive Support forCholine
  15. Choline intake during pregnancy and child cognition at age 7 years.
    Boeke CE; Gillman MW; Hughes MD; Rifas-Shiman SL; Villamor E; Oken E · American journal of epidemiology · 2013
    Cohort study895 participantsCognitive Support forCholine
  16. Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial.
    Sohn M; Park YH; Lim S · Diabetes, obesity & metabolism · 2025
    Randomized trial36 participantsCognitive Support forCholine
  17. Maternal choline supplementation mitigates alcohol exposure effects on neonatal brain volumes.
    Warton FL; Molteno CD; Warton CMR; Wintermark P; Lindinger NM; Dodge NC; Zöllei L; van der Kouwe AJW; Carter RC; Jacobson JL; Jacobson SW; Meintjes EM · Alcoholism, clinical and experimental research · 2022
    Randomized trial52 participantsCognitive Support forCholine
  18. Senile dementia: treatment with deanol.
    Ferris SH; Sathananthan G; Gershon S; Clark C · Journal of the American Geriatrics Society · 1977
    Single-arm trial14 participantsCognitive Support forDeanol
  19. Effects of dimethylaminoethanol pyroglutamate (DMAE p-Glu) against memory deficits induced by scopolamine: evidence from preclinical and clinical studies.
    Blin O; Audebert C; Pitel S; Kaladjian A; Casse-Perrot C; Zaim M; Micallef J; Tisne-Versailles J; Sokoloff P; Chopin P; Marien M · Psychopharmacology · 2010
    Randomized trial24 participantsCognitive Support forDeanol
  20. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo